These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19201468)

  • 1. p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma.
    Sheth N; Yeung J; Chang H
    Leuk Res; 2009 Oct; 33(10):1357-60. PubMed ID: 19201468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
    Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
    J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.
    Pruneri G; Carboni N; Baldini L; Intini D; Colombi M; Bertolini F; Valentini S; Maisonneuve P; Viale G; Neri A
    Hum Pathol; 2003 Jan; 34(1):41-7. PubMed ID: 12605365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study.
    Schwartz TH; Rhiew R; Isaacson SR; Orazi A; Bruce JN
    Neurosurgery; 2001 Nov; 49(5):1039-44; discussion 1044-5. PubMed ID: 11846895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmacytoma in patients with multiple myeloma: morphology and immunohistochemistry.
    Firsova MV; Mendeleeva LP; Kovrigina AM; Solovev MV; Savchenko VG
    BMC Cancer; 2020 Apr; 20(1):346. PubMed ID: 32321465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 deletion may drive the clinical evolution and treatment response in multiple myeloma.
    López-Anglada L; Gutiérrez NC; García JL; Mateos MV; Flores T; San Miguel JF
    Eur J Haematol; 2010 Apr; 84(4):359-61. PubMed ID: 20002730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.
    Ryu D; Kim SJ; Hong Y; Jo A; Kim N; Kim HJ; Lee HO; Kim K; Park WY
    Clin Cancer Res; 2020 Feb; 26(4):935-944. PubMed ID: 31558476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma.
    Ghodke K; Shet T; Epari S; Sengar M; Menon H; Gujral S
    Ann Diagn Pathol; 2015 Jun; 19(3):117-23. PubMed ID: 25842207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell RNA sequencing reveals chemokine self-feeding of myeloma cells promotes extramedullary metastasis.
    Geng S; Wang J; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Wang W; Lyu X; Huang Y; Jing H
    FEBS Lett; 2020 Feb; 594(3):452-465. PubMed ID: 31561267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma.
    Damgaard T; Knudsen LM; Dahl IM; Gimsing P; Lodahl M; Rasmussen T
    Leuk Lymphoma; 2009 Feb; 50(2):236-46. PubMed ID: 19235015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells.
    Govender D; Harilal P; Dada M; Chetty R
    J Clin Pathol; 1997 Jun; 50(6):490-3. PubMed ID: 9378815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.
    Rasmussen T; Kuehl M; Lodahl M; Johnsen HE; Dahl IM
    Blood; 2005 Jan; 105(1):317-23. PubMed ID: 15339850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.
    Liu Y; Jelloul F; Zhang Y; Bhavsar T; Ho C; Rao M; Lewis NE; Cimera R; Baik J; Sigler A; Sen F; Yabe M; Roshal M; Landgren O; Dogan A; Xiao W
    Am J Surg Pathol; 2020 Jun; 44(6):838-848. PubMed ID: 32118627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma.
    Dahl IM; Rasmussen T; Kauric G; Husebekk A
    Br J Haematol; 2002 Feb; 116(2):273-7. PubMed ID: 11841427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
    Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
    PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics of extramedullary manifestations in multiple myeloma.
    Billecke L; Murga Penas EM; May AM; Engelhardt M; Nagler A; Leiba M; Schiby G; Kröger N; Zustin J; Marx A; Matschke J; Tiemann M; Goekkurt E; Heidtmann HH; Vettorazzi E; Dierlamm J; Bokemeyer C; Schilling G
    Br J Haematol; 2013 Apr; 161(1):87-94. PubMed ID: 23368088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetics in multiple myeloma patients progressing into extramedullary disease.
    Besse L; Sedlarikova L; Greslikova H; Kupska R; Almasi M; Penka M; Jelinek T; Pour L; Adam Z; Kuglik P; Krejci M; Hajek R; Sevcikova S
    Eur J Haematol; 2016 Jul; 97(1):93-100. PubMed ID: 26432667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
    Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
    Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal.
    Zhang J; Zhong Y
    Hematol Oncol; 2015 Jun; 33(2):75-9. PubMed ID: 24395149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.